GSK plc (GLAXF)

USD 17.26

(-0.4%)

Total Assets Summary of GSK plc

  • GSK plc's latest annual total assets in 2023 was 59 Billion GBP , down -1.9% from previous year.
  • GSK plc's latest quarterly total assets in 2024 Q1 was 58.51 Billion GBP , down -0.84% from previous quarter.
  • GSK plc reported annual total assets of 60.14 Billion GBP in 2022, down -23.96% from previous year.
  • GSK plc reported annual total assets of 79.1 Billion GBP in 2021, down -1.65% from previous year.
  • GSK plc reported quarterly total assets of 58.51 Billion GBP for 2024 Q1, down -0.84% from previous quarter.
  • GSK plc reported quarterly total assets of 59.46 Billion GBP for 2023 Q2, up 1.48% from previous quarter.

Annual Total Assets Chart of GSK plc (2023 - 1989)

Historical Annual Total Assets of GSK plc (2023 - 1989)

Year Total Assets Total Assets Growth
2023 59 Billion GBP -1.9%
2022 60.14 Billion GBP -23.96%
2021 79.1 Billion GBP -1.65%
2020 80.43 Billion GBP 0.93%
2019 79.69 Billion GBP 37.24%
2018 58.06 Billion GBP 2.99%
2017 56.38 Billion GBP -4.57%
2016 59.08 Billion GBP 10.54%
2015 53.44 Billion GBP 31.48%
2014 40.65 Billion GBP -3.41%
2013 42.08 Billion GBP 1.47%
2012 41.47 Billion GBP 0.96%
2011 41.08 Billion GBP -2.31%
2010 42.05 Billion GBP -1.89%
2009 42.86 Billion GBP 8.81%
2008 39.39 Billion GBP 27.06%
2007 31 Billion GBP 21.33%
2006 25.55 Billion GBP -6.05%
2005 27.19 Billion GBP 18.54%
2004 22.94 Billion GBP 8.23%
2003 21.2 Billion GBP -5.05%
2002 22.32 Billion GBP 1.65%
2001 21.96 Billion GBP 1.74%
2000 21.59 Billion GBP 107.06%
1999 10.42 Billion GBP 11.57%
1998 9.34 Billion GBP 10.77%
1997 8.43 Billion GBP 1.48%
1996 8.31 Billion GBP -2.66%
1995 8.54 Billion GBP 8.29%
1994 7.88 Billion GBP 5.75%
1993 7.45 Billion GBP 31.26%
1992 5.68 Billion GBP -1.08%
1991 5.74 Billion GBP 27.87%
1990 4.49 Billion GBP 29.49%
1989 3.46 Billion GBP 21.0%

Peer Total Assets Comparison of GSK plc

Name Total Assets Total Assets Difference
AstraZeneca PLC 100.97 Billion USD 41.565%
Bristol-Myers Squibb Company PFD CONV 2 95.15 Billion USD 37.993%
CSPC Pharmaceutical Group Limited 6.52 Billion USD -804.428%
Clarus Therapeutics Holdings, Inc. 51.7 Million USD -114011.936%
Novartis AG 99.94 Billion USD 40.963%
PT Kalbe Farma Tbk. 1.75 Billion USD -3254.955%